189 related articles for article (PubMed ID: 11126384)
21. Mutations of p53 gene in hepatocellular carcinoma: roles of hepatitis B virus and aflatoxin contamination in the diet.
Hsia CC; Kleiner DE; Axiotis CA; Di Bisceglie A; Nomura AM; Stemmermann GN; Tabor E
J Natl Cancer Inst; 1992 Nov; 84(21):1638-41. PubMed ID: 1279184
[TBL] [Abstract][Full Text] [Related]
22. Cancer genes and cholangiocarcinoma.
Petmitr S
Southeast Asian J Trop Med Public Health; 1997; 28 Suppl 1():80-4. PubMed ID: 9656355
[TBL] [Abstract][Full Text] [Related]
23. Hepatitis B 1762T/1764A mutations, hepatitis C infection, and codon 249 p53 mutations in hepatocellular carcinomas from Thailand.
Kuang SY; Lekawanvijit S; Maneekarn N; Thongsawat S; Brodovicz K; Nelson K; Groopman JD
Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):380-4. PubMed ID: 15734961
[TBL] [Abstract][Full Text] [Related]
24. Tumor suppressor genes, growth factor genes, and oncogenes in hepatitis B virus-associated hepatocellular carcinoma.
Tabor E
J Med Virol; 1994 Apr; 42(4):357-65. PubMed ID: 8046425
[TBL] [Abstract][Full Text] [Related]
25. Hepatic expression of the proliferative marker Ki-67 and p53 protein in HBV or HCV cirrhosis in relation to dysplastic liver cell changes and hepatocellular carcinoma.
Koskinas J; Petraki K; Kavantzas N; Rapti I; Kountouras D; Hadziyannis S
J Viral Hepat; 2005 Nov; 12(6):635-41. PubMed ID: 16255765
[TBL] [Abstract][Full Text] [Related]
26. microRNAs: Key players in virus-associated hepatocellular carcinoma.
Sadri Nahand J; Bokharaei-Salim F; Salmaninejad A; Nesaei A; Mohajeri F; Moshtzan A; Tabibzadeh A; Karimzadeh M; Moghoofei M; Marjani A; Yaghoubi S; Keyvani H
J Cell Physiol; 2019 Aug; 234(8):12188-12225. PubMed ID: 30536673
[TBL] [Abstract][Full Text] [Related]
27. Hepatitis B, aflatoxin B(1), and p53 codon 249 mutation in hepatocellular carcinomas from Guangxi, People's Republic of China, and a meta-analysis of existing studies.
Stern MC; Umbach DM; Yu MC; London SJ; Zhang ZQ; Taylor JA
Cancer Epidemiol Biomarkers Prev; 2001 Jun; 10(6):617-25. PubMed ID: 11401911
[TBL] [Abstract][Full Text] [Related]
28. Comprehensive analyses of mutations and hepatitis B virus integration in hepatocellular carcinoma with clinicopathological features.
Kawai-Kitahata F; Asahina Y; Tanaka S; Kakinuma S; Murakawa M; Nitta S; Watanabe T; Otani S; Taniguchi M; Goto F; Nagata H; Kaneko S; Tasaka-Fujita M; Nishimura-Sakurai Y; Azuma S; Itsui Y; Nakagawa M; Tanabe M; Takano S; Fukasawa M; Sakamoto M; Maekawa S; Enomoto N; Watanabe M
J Gastroenterol; 2016 May; 51(5):473-86. PubMed ID: 26553052
[TBL] [Abstract][Full Text] [Related]
29. The p53 mutation spectrum in hepatocellular carcinoma from Guangxi, China : role of chronic hepatitis B virus infection and aflatoxin B1 exposure.
Qi LN; Bai T; Chen ZS; Wu FX; Chen YY; De Xiang B; Peng T; Han ZG; Li LQ
Liver Int; 2015 Mar; 35(3):999-1009. PubMed ID: 24461059
[TBL] [Abstract][Full Text] [Related]
30. Etiological and molecular profile of hepatocellular cancer from India.
Asim M; Sarma MP; Kar P
Int J Cancer; 2013 Jul; 133(2):437-45. PubMed ID: 23233429
[TBL] [Abstract][Full Text] [Related]
31. Mutation inactivation of Nijmegen breakage syndrome gene (NBS1) in hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
Wang Y; Hong Y; Li M; Long J; Zhao YP; Zhang JX; Li Q; You H; Tong WM; Jia JD; Huang J
PLoS One; 2013; 8(12):e82426. PubMed ID: 24349281
[TBL] [Abstract][Full Text] [Related]
32. Mutations of the p53 tumor suppressor gene and the ras gene family in intrahepatic cholangiocellular carcinomas in Japan and Thailand.
Kiba T; Tsuda H; Pairojkul C; Inoue S; Sugimura T; Hirohashi S
Mol Carcinog; 1993; 8(4):312-8. PubMed ID: 8280380
[TBL] [Abstract][Full Text] [Related]
33. Pathogenesis of hepatitis B and C-induced hepatocellular carcinoma.
Idilman R; De Maria N; Colantoni A; Van Thiel DH
J Viral Hepat; 1998 Sep; 5(5):285-99. PubMed ID: 9795912
[TBL] [Abstract][Full Text] [Related]
34. Mutations of the p53 tumor suppressor gene and ras oncogenes in aflatoxin hepatocarcinogenesis.
Shen HM; Ong CN
Mutat Res; 1996 Oct; 366(1):23-44. PubMed ID: 8921985
[TBL] [Abstract][Full Text] [Related]
35. Viral hepatitis-associated intrahepatic cholangiocarcinoma shares common disease processes with hepatocellular carcinoma.
Lee CH; Chang CJ; Lin YJ; Yeh CN; Chen MF; Hsieh SY
Br J Cancer; 2009 Jun; 100(11):1765-70. PubMed ID: 19436294
[TBL] [Abstract][Full Text] [Related]
36. Liver stem cells: implications for hepatocarcinogenesis.
Alison MR
Stem Cell Rev; 2005; 1(3):253-60. PubMed ID: 17142862
[TBL] [Abstract][Full Text] [Related]
37. [The research progress in clinicopathological characteristics and treatment of hepatitis B virus-associated intrahepatic cholangiocarcinoma].
Tang ZH; Tong HJ; Quan ZW
Zhonghua Wai Ke Za Zhi; 2020 Apr; 58(4):280-283. PubMed ID: 32241057
[TBL] [Abstract][Full Text] [Related]
38. p53 gene mutation and integrated hepatitis B viral DNA sequences in human liver cancer cell lines.
Hsu IC; Tokiwa T; Bennett W; Metcalf RA; Welsh JA; Sun T; Harris CC
Carcinogenesis; 1993 May; 14(5):987-92. PubMed ID: 8389256
[TBL] [Abstract][Full Text] [Related]
39. Hepatocellular carcinoma: an update.
Dominguez-Malagón H; Gaytan-Graham S
Ultrastruct Pathol; 2001; 25(6):497-516. PubMed ID: 11783914
[TBL] [Abstract][Full Text] [Related]
40. Genetic aspects of hepatocellular carcinogenesis.
Ozturk M
Semin Liver Dis; 1999; 19(3):235-42. PubMed ID: 10518303
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
